Alembic Pharma gets USFDA final approval for Fesoterodine Fumarate 0 06.01.2023 08:29 Business Standard The drug maker has received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Fesoterodine Fumarate extended-release tablets, 4 mg and 8 mg. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
